Comparison of Global, G-TL, & Cornell Media

NCT ID: NCT03687697

Last Updated: 2018-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2018-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, randomized clinical trial to compare the Global commercial single step media to 1) G-TL (Vitrolife), 2) Weill Cornell's single step and sequential steps media, which all support human embryo development in the laboratory using the Vitrolife Time-Lapse system. The main goal of the study is to identify the best culture medium for optimal embryo development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Culture media are used to culture embryos in order to support their development in the laboratory. New media are being introduced to the market. Clinical studies have shown that the use of the single-step Global medium for culture of human embryos from the zygote stage to the blastocyst stage has resulted in better in-vitro development than a variety of sequential media system.

Global is a FDA approved commercial single-step medium for all embryo culture from Day 0 to the blastocyst stage.

G-TL (Time-Lapse) is a FDA approved commercial single-step medium from Vitrolife. It was developed to be used with time-lapse devices as a continuous embryo culture medium from Day 0 to Day 5/6.

C3 is Cornell's in house made single-step buffered medium for embryo culture from oocyte fertilization to blastocyst stage used as standard of care.

C1/C2 is Cornell's in house made buffered sequential medium otherwise known as multi step medium, use to culture embryos for development. It is formulated to meet the embryos requirements at two specific stages of development but require removal of the dish from the incubator to physically exchange the culture media surrounding the embryos. This medium will be the control.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Global vs. G-TL Media

Global medium will be compared with G-TL (Time-Lapse) medium.

Group Type EXPERIMENTAL

Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media

Intervention Type BIOLOGICAL

A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.

Global vs. Cornell's C3 Media

Global medium will be compared with Cornell's C3 single step medium.

Group Type EXPERIMENTAL

Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media

Intervention Type BIOLOGICAL

A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.

Global vs. Cornell's sequential Media

Global medium will be compared with Cornell's C1/C2 sequential medium.

Group Type EXPERIMENTAL

Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media

Intervention Type BIOLOGICAL

A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media

A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 40 years of age or younger (maternal)
* 65 years of age or younger (paternal)
* 10 or more oocytes
* Fresh or frozen oocytes (including donor)
* Fresh or frozen (including donor) sperm can be used
* ICSI only
* Frozen embryos from this study can be included in the outcome portion of this study.
* PGD and/or PGS patients included

Exclusion Criteria

* Patients with less than 10 oocytes
* Co-culture patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Weill Medical College of Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nikica Zaninovic, PhD

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center for Reproductive Medicine

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1707018347

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immune Modulators and IVF
NCT02626702 TERMINATED
Fertilo In Vitro Research Study and Trial
NCT06858111 RECRUITING PHASE3